The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
Azithromycin blocks autophagy and may predispose cystic fibrosis patients to mycobacterial infection
Open accessAbstract
Azithromycin is a potent macrolide antibiotic with poorly understood antiinflammatory properties. Long-term use of azithromycin in patients with chronic inflammatory lung diseases, such as cystic fibrosis (CF), results in improved outcomes. Paradoxically, a recent study reported that azithromycin use in patients with CF is associated with increased infection with nontuberculous mycobacteria (NTM). Here, we confirm that long-term azithromycin use by adults with CF is associated with the development of infection with NTM, particularly the multi-drug-resistant species Mycobacterium abscessus, and identify an underlying mechanism. We found that in primary human macrophages, concentrations of azithromycin achieved during therapeutic dosing blocked autophagosome clearance by preventing lysosomal acidification, thereby impairing autophagic and phagosomal degradation. As a consequence, azithromycin treatment inhibited intracellular killing of mycobacteria within macrophages and resulted in chronic infection with NTM in mice. Our findings emphasize the essential role for autophagy in the host response to infection with NTM, reveal why chronic use of azithromycin may predispose to mycobacterial disease, and highlight the dangers of inadvertent pharmacological blockade of autophagy in patients at risk of infection with drug-resistant pathogens.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
LC3, a mammalian homologue of yeast Apg8p, is localized in autophagosome membranes after processing.
Kabeya, Y., Mizushima, N., Ueno, T., Yamamoto, A., Kirisako, T., Noda, T., Kominami, E., Ohsumi, Y., & Yoshimori, T. (2000) · The EMBO Journal · doi:10.1093/emboj/19.21.5720 · Cited by 6,605
Griffith, D. E., Aksamit, T., Brown-Elliott, B. A., Catanzaro, A., Daley, C., Gordin, F., Holland, S. M., Horsburgh, R., Huitt, G., Iademarco, M. F., et al. (2007) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200604-571st · Cited by 6,110
Ravikumar, B., Vacher, C., Berger, Z., Davies, J. E., Luo, S., Oroz, L. G., Scaravilli, F., Easton, D. F., Duden, R., O'Kane, C. J., et al. (2004) · Nature Genetics · doi:10.1038/ng1362 · Cited by 2,347
Self-citationGutierrez, M. G., Master, S. S., Singh, S. B., Taylor, G. A., Colombo, M. I., & Deretic, V. (2004) · Cell · doi:10.1016/j.cell.2004.11.038 · Cited by 2,252
Guidelines for the use and interpretation of assays for monitoring autophagy in higher eukaryotes
Klionsky, D. J., Abeliovich, H., Agostinis, P., Agrawal, D. K., Aliev, G., Askew, D. S., Baba, M., Baehrecke, E. H., Bahr, B. A., Ballabio, A., et al. (2008) · Autophagy · doi:10.4161/auto.5338 · Cited by 2,230 · cited 4×
“We next examined whether inhibition of LC3-II clearance by azithromycin was caused by failure of autophagosome-lysosome fusion, as seen with long-term treatment with BafA1 treatment (11), or failure of lysosomal function, a mechanism we recently reported (19).”
BackgroundInfluentialSelf-citationThe role of autophagy in cancer development and response to therapy
Kondo, Y., Kanzawa, T., Sawaya, R., & Kondo, S. (2005) · Nature Reviews Cancer · doi:10.1038/nrc1692 · Cited by 1,654
α-Synuclein Is Degraded by Both Autophagy and the Proteasome
Webb, J. L., Ravikumar, B., Atkins, J., Skepper, J. N., & Rubinsztein, D. C. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m300227200 · Cited by 1,429
Self-citationp62 at the crossroads of autophagy, apoptosis, and cancer
Moscat, J., & Diaz-Meco, M. T. (2009) · Cell · doi:10.1016/j.cell.2009.05.023 · Cited by 1,073
Human IRGM Induces Autophagy to Eliminate Intracellular Mycobacteria
Singh, S. B., Davis, A. S., Taylor, G. A., & Deretic, V. (2006) · Science · doi:10.1126/science.1129577 · Cited by 915
Nash, K. A., Brown-Elliott, B. A., & Wallace, R. J. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01275-08 · Cited by 638
CFTR regulates phagosome acidification in macrophages and alters bactericidal activity
Di, A., Brown, M. E., Deriy, L. V., Li, C., Szeto, F. L., Chen, Y., Huang, P., Tong, J., Naren, A. P., Bindokas, V., et al. (2006) · Nature Cell Biology · doi:10.1038/ncb1456 · Cited by 492
T Helper 2 Cytokines Inhibit Autophagic Control of Intracellular Mycobacterium tuberculosis
Harris, J., De Haro, S. A., Master, S. S., Keane, J., Roberts, E. A., Delgado, M., & Deretic, V. (2007) · Immunity · doi:10.1016/j.immuni.2007.07.022 · Cited by 460
Chronic Mycobacterium abscessus infection and lung function decline in cystic fibrosis
Esther, C. R., Esserman, D. A., Gilligan, P., Kerr, A., & Noone, P. G. (2010) · Journal of Cystic Fibrosis · doi:10.1016/j.jcf.2009.12.001 · Cited by 410
Roux, A.-L., Catherinot, E., Ripoll, F., Soismier, N., Macheras, E., Ravilly, S., Bellis, G., Vibet, M.-A., Le Roux, E., Lemonnier, L., et al. (2009) · Journal of Clinical Microbiology · doi:10.1128/jcm.01257-09 · Cited by 322
Loss of function of a lupus-associated FcγRIIb polymorphism through exclusion from lipid rafts
Floto, R. A., Clatworthy, M. R., Heilbronn, K. R., Rosner, D. R., MacAry, P. A., Rankin, A., Lehner, P. J., Ouwehand, W. H., Allen, J. M., Watkins, N. A., et al. (2005) · Nature Medicine · doi:10.1038/nm1288 · Cited by 316
Self-citationAzithromycin Reverses Airflow Obstruction in Established Bronchiolitis Obliterans Syndrome
Yates, B., Murphy, D. M., Forrest, I. A., Ward, C., Rutherford, R. M., Fisher, A. J., Lordan, J. L., Dark, J. H., & Corris, P. A. (2005) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200411-1537oc · Cited by 228
Levy, I., Grisaru-Soen, G., Lerner-Geva, L., Kerem, E., Blau, H., Bentur, L., Aviram, M., Rivlin, J., Picard, E., Lavy, A., et al. (2008) · Emerging Infectious Diseases · doi:10.3201/eid1403.061405 · Cited by 201
A molecular investigation of true dominance in Huntington’s disease
Narain, Y., Wyttenbach, A., Rankin, J., Furlong, R. A., & Rubinsztein, D. C. (1999) · Journal of Medical Genetics · doi:10.1136/jmg.36.10.739 · Cited by 158
Self-citationGreendyke, R., & Byrd, T. F. (2008) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00986-07 · Cited by 150
Animal model ofMycobacterium abscessuslung infection
Ordway, D. J., Henao-Tamayo, M. I., Smith, E. E., Shanley, C. A., Harton, M. R., Troudt, J. M., Bai, X., Basaraba, R. J., Orme, I. M., & Chan, E. D. (2008) · Journal of Leukocyte Biology · doi:10.1189/jlb.1007696 · Cited by 132
Self-citationRole of macrolide therapy in chronic obstructive pulmonary disease
Martínez, F. J. (2008) · International Journal of COPD · doi:10.2147/copd.s681 · Cited by 125
PIACENTINI, G. L., Peroni, D. G., Bodini, A., Pigozzi, R., Costella, S., Loiacono, A., & Boner, A. L. (2007) · Allergy and Asthma Proceedings · doi:10.2500/aap.2007.28.2958 · Cited by 116
Autophagy in Immune Defense Against Mycobacterium tuberculosis
Vergne, I., Singh, S., Roberts, E., Kyei, G., Master, S., Harris, J., Haro, S. D., Naylor, J., Davis, A., Delgado, M., et al. (2006) · Autophagy · doi:10.4161/auto.2830 · Cited by 79
Wilms, E. B., Touw, D. J., & Heijerman, H. G. M. (2006) · Therapeutic Drug Monitoring · doi:10.1097/01.ftd.0000195617.69721.a5 · Cited by 79
The possibility of eliminating blinding trachoma
Mecaskey, J. W., Knirsch, C. A., Kumaresan, J., & Cook, J. A. (2003) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(03)00807-7 · Cited by 57
Fréhel, C., Offredo, C., & de Chastellier, C. (1997) · Infection and Immunity · doi:10.1128/iai.65.7.2792-2802.1997 · Cited by 36
McArdle, J. R., & Talwalkar, J. S. (2007) · Clinics in Chest Medicine · doi:10.1016/j.ccm.2007.02.005 · Cited by 34
Azithromycin therapy for neutrophilic airways disease: myth or magic?
Idris, S. F., Chilvers, E. R., HAWORTH, C. S., McKeon, D. J., & Condliffe, A. M. (2009) · Thorax · doi:10.1136/thx.2008.103192 · Cited by 31
Self-citationWilms, E. B., Touw, D. J., & Heijerman, H. G. M. (2007) · Journal of Cystic Fibrosis · doi:10.1016/j.jcf.2007.05.005 · Cited by 30
Jahreiss, L., Renna, M., Bittman, R., Arthur, G., & Rubinsztein, D. C. (2009) · Autophagy · doi:10.4161/auto.9120 · Cited by 29
Self-citationWilliams, T. J., & Verleden, G. M. (2005) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.2506011 · Cited by 22
Cited by
Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition) 1
Klionsky, D. J., Abdel-Aziz, A. K., Abdelfatah, S., Abdellatif, M., Abdoli, A., Abel, S., Abeliovich, H., Abildgaard, M. H., Abudu, Y. P., Acevedo-Arozena, A., et al. (2021) · Autophagy · doi:10.1080/15548627.2020.1797280 · Cited by 2,897
Self-citationAutophagy modulation as a potential therapeutic target for diverse diseases
Rubinsztein, D. C., Codogno, P., & Levine, B. (2012) · Nature Reviews Drug Discovery · doi:10.1038/nrd3802 · Cited by 1,437
Self-citationBeceiro, A., Tomás, M., & Bou, G. (2013) · Clinical Microbiology Reviews · doi:10.1128/cmr.00059-12 · Cited by 1,070
Pharmacological modulation of autophagy: therapeutic potential and persisting obstacles
Galluzzi, L., Bravo-San Pedro, J. M., Levine, B., Green, D. R., & Kroemer, G. (2017) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2017.22 · Cited by 842
Haworth, C. S., Banks, J., Capstick, T., Fisher, A. J., Gorsuch, T., Laurenson, I. F., Leitch, A., Loebinger, M. R., Milburn, H. J., Nightingale, M., et al. (2017) · Thorax · doi:10.1136/thoraxjnl-2017-210927 · Cited by 785
Self-citation
Metadata
- Authors
- Renna, M., Schaffner, C., Brown, K., Shang, S., Tamayo, M. H., Hegyi, K., Grimsey, N. J., Cusens, D., Coulter, S., Cooper, J., Bowden, A. R., Newton, S. M., Kampmann, B., Helm, J., Jones, A., Haworth, C. S., Basaraba, R. J., DeGroote, M. A., Ordway, D. J., Rubinsztein, D. C., & Floto, R. A.
- Venue
- Journal of Clinical Investigation
- Published
- 2011-09-01
- Volume
- 121
- Issue
- 9
- Pages
- 3554-3563
- ISSN
- 0021-9738 (ISSN-L)
- OpenAlex
- W2016283787
- Cited by
- 314
- References
- 31
- FWCI
- 18.15
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.